NCPA submitted comments to the Centers for Medicare & Medicaid Services on its prior authorization proposed rule. NCPA largely endorsed the comments sent by NCPDP, supported CMS’ announcement to pledge to advance electronic prior authorization, and advised the agency against causing additional undue administrative burden for pharmacists. NCPA also opposed step therapy used by PBMs and plans that forces patients to repeat previously unsuccessful therapies after switching plans or coverage.
Read the comments here.
NCPA
